Nigeria Experience in Determining that Loiasis Presented No Risk to Ivermectin Treatment for Onchocerciasis
DOI:
https://doi.org/10.4314/njpar.v46i1.3Keywords:
Nigerian, Onchocerciasis-loiasis co-endemicity, RAPLOA, SAEsAbstract
Nigeria accounts for approximately 40% of the global onchocerciasis burden, affecting more than 50 million people. Onchocerciasis constitutes a major social and public health problem and therefore cannot be taken for granted. The discovery and free donation of ivermectin (Mectizan®) encouraged Nigeria and other endemic countries to implement Mass Drug Administration (MDA) in at-risk population. Unfortunately, reports from some onchocerciasis-endemic African countries where onchocerciasis is co-endemic with Loa loa indicate that Severe Adverse Events (SAEs) may occur in patients who have taken ivermectin. This threatens the success of the onchocerciasis control/elimination programme in many of these onchocerciasis-endemic African countries where Loa loa is co-endemic. Nigeria commenced MDA in 1988 in endemic communities of Kwara
and Kaduna States and later expended MDA to nearly all the transmission zones and tens of millions of people have been treated with ivermectin including areas presumed to be onchocerciasis-loiasis co-endemic zone. One striking observation is that there was no evidence of SAEs in Nigeria. Of the 758 SAEs reported to the Mectizan Donation Program between 1990 and 2014, only one suspicious case (0.1%) was reported in Nigeria (around Kwara State, a non-loiasis belt). The international scientific community has continued to ask questions concerning this.
For instance, the WHO Loa loa Expert Committee met in Paris, France, August 28-30, 2024 and wanted to know the Nigerian experience in determining that loiasis presented no risk to ivermectin treatment for onchocerciasis. In doing so, the Expert Committee asked the following questions: (a) what are the Rapid Epidemiological Mapping of Loiasis (RAPLOA) exercises in Nigeria; (b) what is
the more recent data collected on Loa loa microfilaria density that led Nigeria to determine that MDA for onchocerciasis was safe; (c) do Nigerians think that the RAPLOA data differed so much from the microfilaria density data?, and (d) did loiasis endemicity change over time or is the relationship between RAPLOA and mf density different in Nigeria? As the Chairman of Nigerian Onchocerciasis Elimination Committee (NOEC), the present work addresses these programmatic
questions.
References
Okonkwo, O. N., Hassan, A. O., Alarape, T., Akanbi, T., Oderinlo, O., Akinye, A. & Oyekunle, I. (2018) Removal of adult subconjunctival Loa loa amongst urban dwellers in Nigeria. PLoS Neglected Tropical Diseases, 12(11): e0006920. https://doi.org/10.1371/journal.pntd.0006920
Kelly-Hope, L. A., Bockarie, M. J., & Molyneux, D. H. (2012). Loa loa ecology in Central Africa: Role of the Congo River system. PLoS Neglected Tropical Diseases, 6(6):e1605, doi: 10.1371/journal.pntd.0001605, PMCID: PMC3383754. https://doi.org/10.1371/journal.pntd.0001605
Nnochiri, E. (1975) Medical Parasitology in the Tropics. Oxford University Press, London, pp: 193, ISBN-13:978-0192642257
Thomson, M. C., Obsomer, V., Dunne, M., Connor, S. J., & Molyneux, D. H. (2000). "Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa". The Lancet, 356(9235): 1077–1078. doi: 10.1016/s0140-6736(00)02733-PMID: 11009145.
Whittaker, C., Walker, M., Pion, S.D.S., Chesnais, C. B., Boussinesq, M., & Basanez, M. G. (2018). The Population Biology and Transmission Dynamics of Loa loa. Trends in Parasitology, 34(4): 335-350, doi:10.1016/j.pt.2017.12.003, PMID: 29331268.,
Center for Disease Control (2015). Parasites – Loiasis. Global Health Division of Parasitic Diseases, Centers for Disease Control and Prevention, CDC, Atlanta GA USA, https://www.cdc.gov › dpdx › loiasis
World Health Organization (2016) Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis: Criteria and procedures. WHO/HTM/NTD/PCT/2016.1, WHO Geneva https://www.who.int › Publications › i › item
Chippaux, J. P., Boussinesq, M., Gardon, J., Gardon-Wendel, N., & Ernould, J. C. (1996). Severe adverse reaction risk during mass treatment with ivermectin in loiasis-endemic area. Parasitology Today, 12: 448-4 5 0 . C:UsersufekpAppDataLocalTempufekpDropboxNJP_Editor_in-ChiefEkpoUF_EICManuscript_Submisison2024_ManuscriptsSeptember 2024NJP 751_NwokeRevisions
https:www.semanticscholar.org › paper › Severe-adve... , doi: 10.1016/0169-4758(96)40006-0. PMID: 15275280, https://www.semanticscholar.org › paper › Severe-adve...
Gardon, J., Gardon-Wendel, N., Demanga-Ngangue, Kamgno, J., Chippaux, J. P., & Boussinesq, M. (1997). Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet (London, England), 350(9070), 18–22, doi: 10.1016/S0140-6736(96)11094-1. PMID: 9217715. https://doi.org/10.1016/S0140-6736(96)11094-1,
World Health Organization/Tropical Disease Research (2002) Guidelines for rapid assessment of Loa loa. Geneva: UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases TDR,/IDE/RAPLOA/02.1
TDR/IDE/RAPLOA/02.1 , TDR/WHO Geneva, https://www.who.int › Publications › i › item
World Health Organization (1987). WHO Expert Committee on Onchocerciasis. WHO Technical. Report Series. No. 752, WHO Geneva. https://iris.who.int › WHO_TRS_752_
Nwoke, B.E. B., Dozie, I. N. S., Jiya, J. Y., & Gemade, E. I. I. (1999). The present status of human onchocerciasis in South-eastern Nigeria using rapid epidemiological mapping of onchocerciasis (REMO). Nigerian Journal of Parasitology, 19: 11-18. https://pubmed.ncbi.nlm.nih.gov › ...
Federal Ministry of Health (2009), Exit Strategy of APOC from Nigeria, National Onchocerciasis Task Force, Nigeria, Federal Ministry of Health, Abuja, Nigeria
Federal Ministry of Health (2002). Second National Plan of Action for the Control of Onchocerciasis in Nigeria, 2003- 2013. Federal Ministry of Health, Abuja, Nigeria
Nwoke, B E B., Akpan, N., Cama, C., Ekpo, U. F., Idyorough, A. E., Mafe, M. A., Mafuyai, H. B., Makata, E., Miri, E., Opara, K. & Richards, F. (2023), Onchocerciasis in Nigeria 1: Historical background of control efforts, Nigerian Journal of Parasitology Special Issue online Publication, Special Issue [1] May 2023: 1-26, https://njpar.com.ng/index.php/home/article/view/356
Federal Ministry of Health (2024), Communiqué of the 18th NOEC Meeting, Federal Ministry of Health, Abuja, Nigeria.
Twum-Danso, N. A. (2003). Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future. Filaria Journal, 2 (Suppl 1): S7, doi: 10.1186/1475-2883-2-S1-S7. PMID: 14975064; https://www.ncbi.nlm.nih.gov › articles ›
Kershaw, W. E. (1950), Studies on the epidemiology of filariasis in West Africa, with special reference to the British Cameroon and the Niger Delta. I. Methods of survey for infections with Loa loa and Acanthocheinema perstans. Annals of Tropical Medicine and Parasitology, 44:361-378. doi: 10.1080/00034983.1950.11685462., https://pubmed.ncbi.nlm.nih.gov
Ogunba, E. O. (1977). Loa loa microfilaraemia in the Nigerian population. Tropical and Geographical Medicine, 29: 51-55. https://pubmed.ncbi.nlm.nih.gov › , PMID: 268074.
Udonsi, J. K. (1988). Filariasis in Igwun River Basin, Nigeria: An epidemiological and clinical study with a note on the vectors. Annals of Tropical Medicine and Parasitology, 82:75-82 doi:10.1080/00034983.1988.11812212., https://www.tandfonline.com
Ufomadu, G. O., Nwoke, B. E. B., Akoh, J. I., Sato, Y., Ekejindu, G. O., Uchida, A., Shiwaku, K., Tumbau, M., & Ugomo, K. K. (1990), The occurrence of loiasis, mansonellosis, and wuchereriasis in the Jarawa River Valley, central Nigeria. Acta Tropica, 48(2): 137-147, https://doi.org/10.1016/0001-706X(90)90053-3
World Health Organization/Tropical Disease Research (2001), Rapid Assessment Procedures For Loiasis TDR/IDE/RP/RAPL/01.1, WHO, Geneva, https://iris.who.int › bitstream › handle ›
Takougang, I., Meremikwu, M., Wandji, S., Yenshu, E. V., Aripko, B., Lamlenn, S. M., Eka, B. L., Enyong, P., Meli, J., Kale, O. O. & Remme, J. H. (2002), Rapid assessment method for prevalence and intensity of Loa loa infection, Bulletin of World Health Organization, 80:852–858, PMID: 12481206; PMCID: PMC2567678., https://pubmed.ncbi.nlm.nih.gov ,
Zouré, H. G., Wanji, S., Noma, M., Amazigo, U. V., Diggle, P. J., Tekle, A. H., & Remme, J. H. (2011). The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA). PLoS Neglected Tropical Diseases, 5(6), e1210. doi: 10.1371/journal.pntd.0001210. https://doi.org/10.1371/journal.pntd.0001210
Diawara, L., Traore, M. O., Badji, A., Bissan, Y., Doumbia, K., Goita, S. F., & Konaté, L. (2009). Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Neglected Tropical Diseases, 3(7): e497, https://doi.org/10.1371/journal.pntd.0000497
World Health Organization/African Programme for Onchocerciasis Control (2012), Conceptual and Operational Issues in Onchocerciasis Elimination with Ivermectin Treatment, JAF16.6(II)., 2010WHO/APOC Document, Burkina Faso, https://journals.plos.org › plosntds › article › journal.pn
Federal Ministry of Health (2017). Nigeria Onchocerciasis Elimination Plan. Abuja, Nigeria: Federal Ministry of Health, Abuja, Nigeria.
Emukah, E., Rakers, L. J., Kahansim, B., Miri, E. S., Nwoke, B. E. B., Griswold, E., Saka, Y., Anagbogu, I., Davies, E., Ityonzughul, C., D'Ambrosio, M., Bakalar, M., Fletcher, D. A., Nutman, T., Kamgno, J., & Richards, F. O. (2018). In Southern Nigeria Loa loa blood microfilaria density is very low even in areas with high prevalence of loiasis: Results of a survey using the new LoaScope technology. American Journal of Tropical Medicine & Hygiene, 99(1): 116-123. doi: 10.4269/ajtmh.18-0163, https://europepmc.org › article › pmc
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Nigerian Journal of Parasitology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
